32 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 19 Phase 3, 10 Phase 2, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 19 | Completed 19 |
| Phase 2 | 10 | Completed 9, Terminated 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Completed 1 |
Follow Neisseria Meningitidis: new trials by email Literature Review of Neisseria Meningitidis trials Research Report on Neisseria Meningitidis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metagenomic Analysis of the Pharynx in High Risk Partners Gonorrhea, Neisseria Gonorrhea | Not yet recruiting | Guy's and St Thomas' NHS Foundation Trust | 100 | 2026-07-14 | 2026-06-30 | |
| MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults Trumenba, PENBRAYA - Neisseria Meningitidis | Phase 4 | Recruiting | Emory University | 125 | 2025-11-04 | 2025-12-22 |
| Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers Neisseria Meningitidis | Completed | University of Adelaide | 6802 | 2018-02-01 | 2021-11-05 | |
| Investigating Meningococcal Vaccines in Adults 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics - Meningococcal Vaccines, Meningococcal Infections | Not applicable | Completed | University of Oxford | 15 | 2015-04-01 | 2021-10-27 |
| Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age Hib-MenCY-TT (MenHibrix®), Pediarix®, Rotarix® - Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 600 | 2014-02-01 | 2018-09-14 |
| Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) PR5I, Pediacel®, NeisVac-C® - Neisseria Meningitidis, Bacterial Infections | Phase 3 | Completed | MCM Vaccines B.V. | 385 | 2013-05-01 | 2019-02-25 |
| Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination Hexavalent vaccine, NeisVac-C, Prevenar 13 - Neisseria Meningitidis, Bacterial Infections | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 350 | 2013-04-01 | 2017-09-11 |
| Neisseria Meningitidis Burden of Disease Study Data collection, CSF samples testing - Streptococcus Pneumoniae, Neisseria Meningitidis | Completed | GlaxoSmithKline | 521 | 2013-01-01 | 2015-11-11 | |
| Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC) MenBvac - Neisseria Meningitidis | Phase 3 | Completed | University Hospital, Rouen | 120 | 2012-04-01 | 2026-06-12 |
| Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) V419, PREVNAR 13®, MCC-TT - Neisseria Meningitidis, Bacterial Infections | Phase 3 | Completed | MCM Vaccines B.V. | 284 | 2012-03-30 | 2019-03-28 |
| NeisVac-C Single Prime Study in Infants Meningococcal group C polysaccharide conjugate vaccine, Pneumococcal 13-valent conjugate vaccine, Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccine - Neisseria Meningitidis | Phase 3 | Completed | Pfizer | 956 | 2010-09-01 | 2015-05-21 |
| Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants GSK2202083A vaccine, Prevenar 13®, Infanrix hexa™ - Tetanus, Hepatitis B | Phase 2 | Completed | GlaxoSmithKline | 480 | 2010-05-17 | 2018-08-20 |
| Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants GSK2197870A, Prevenar™, Menitorix™ - Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 2 | Completed | GlaxoSmithKline | 284 | 2009-06-24 | 2018-06-06 |
| Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines MenitorixTM, Pneumococcal conjugate vaccine GSK1024850A, PrevenarTM - Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 3 | Completed | GlaxoSmithKline | 582 | 2009-05-14 | 2018-02-15 |
| Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. GSK2202083A vaccine, Infanrix hexa, Menjugate - Tetanus, Poliomyelitis | Phase 2 | Terminated | GlaxoSmithKline | 16 | 2009-04-01 | 2018-06-06 |
| Dose Comparison Study of Menactra® in US Children Menactra®: Meningococcal Polysaccharide Diphtheria Conjugate - Meningitis, Meningococcal Infection | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 333 | 2008-06-01 | 2016-04-14 |
| Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants Menitorix™, Infanrix™ penta, Prevenar™ - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Completed | GlaxoSmithKline | 313 | 2007-12-01 | 2018-08-27 |
| Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014), PedvaxHIB, Prevnar - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Completed | GlaxoSmithKline | 4021 | 2007-07-01 | 2016-11-29 |
| Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine Menitorix, Infanrix IPV - Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 4 | Completed | GlaxoSmithKline | 288 | 2007-05-16 | 2020-06-16 |
| Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine, Mencevax®: Group A, C, W135 and Y polysaccharide meningococcal vaccine - Neisseria Meningitidis, Meningococcal Infections | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 450 | 2007-02-01 | 2015-07-14 |
Showing 20 of 35. Sign in to see all of them.
Haemophilus Infections (22) · Meningococcal Infections (6) · Bacterial Infections (3) · Virus Diseases (3) · Diphtheria (2) · Hepatitis B (2) · Meningitis (2) · Poliomyelitis (2) · Tetanus (2) · Gonorrhea (1) · Meningitis, Meningococcal (1)
Bacterial Infections and Mycoses (30) · Infections (30) · Bacterial Infections (27) · Gram-Negative Bacterial Infections (27) · Pasteurellaceae Infections (22) · Neisseriaceae Infections (7) · Nervous System Diseases (5) · Neuroinflammatory Diseases (5) · Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Communicable Diseases (3) · Actinomycetales Infections (2) · Blood-Borne Infections (2) · Clostridium Infections (2) · Corynebacterium Infections (2)
Heptavalent Pneumococcal Conjugate Vaccine (7) · Vaccines (7) · 13-valent pneumococcal vaccine (6) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (6) · Hib-MenCY-TT vaccine (5) · Measles-Mumps-Rubella Vaccine (5) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (5) · Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (4) · Meningococcal Vaccines (4) · PEDIARIX (4) · Chickenpox Vaccine (3) · DTPa-HBV-IPV combined vaccine (2) · Hepatitis B Vaccines (2) · RIX4414 vaccine (2) · RotaTeq (2)
GlaxoSmithKline (22) · Sanofi Pasteur, a Sanofi Company (4) · MCM Vaccines B.V. (2) · Emory University (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Pfizer (1) · Public Health England (1) · University Hospital, Rouen (1) · University of Adelaide (1) · University of Oxford (1)
United States (9) · Spain (6) · Australia (5) · Poland (4) · United Kingdom (4) · Germany (3) · Mexico (3) · Finland (2) · France (2) · Belgium (1) · Canada (1) · Italy (1) · Philippines (1) · Saudi Arabia (1) · Slovakia (1)
Christina Rostad, MD (1) · Elizabeth Miller, MBBS FRCPath (1) · Helen Marshall (1)
PMID 22327493, PMID 16861642, PMID 17072120, PMID 18463125, PMID 23340564, PMID 27145999, PMID 27847367, PMID 27939054, PMID 28583305, PMID 30471953, PMID 34487174, PMID 35895880, PMID 41045941